🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
316,13 USD
Máx. histórico
322,75
5 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,05%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+0,83%
Cierre anterior
313,52
Rango de hoy
309,86 – 319,18
Volumen hoy
179.912
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 124,46 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 23 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 28/12/2020 | 66,84 | 66,84 | 64,45 | 64,66 | -2,26% | 3,57% | 325.890 |
| 24/12/2020 | 66,31 | 66,57 | 65,54 | 66,16 | +0,36% | 1,55% | 260.167 |
| 23/12/2020 | 64,84 | 67,05 | 64,12 | 65,92 | +2,41% | 4,51% | 385.361 |
| 22/12/2020 | 62,42 | 64,97 | 61,63 | 64,37 | +3,76% | 5,35% | 368.530 |
| 21/12/2020 | 60,71 | 62,33 | 60,41 | 62,03 | +0,34% | 3,16% | 336.470 |
| 18/12/2020 | 63,06 | 63,51 | 61,46 | 61,82 | -1,57% | 3,24% | 1.202.571 |
| 17/12/2020 | 59,83 | 62,96 | 58,98 | 62,81 | +5,13% | 6,64% | 447.878 |
| 16/12/2020 | 60,34 | 61,18 | 58,87 | 59,74 | -1,51% | 3,82% | 417.902 |
| 15/12/2020 | 64,33 | 64,63 | 59,64 | 60,66 | -4,47% | 7,76% | 757.257 |
| 14/12/2020 | 58,10 | 67,37 | 58,10 | 63,50 | +9,64% | 15,97% | 1.780.933 |
| 11/12/2020 | 57,43 | 59,19 | 56,80 | 57,92 | +0,78% | 4,16% | 468.878 |
| 10/12/2020 | 55,97 | 58,29 | 55,63 | 57,47 | +2,07% | 4,75% | 551.432 |
| 09/12/2020 | 54,95 | 56,39 | 54,60 | 56,30 | +3,12% | 3,25% | 394.338 |
| 08/12/2020 | 53,96 | 54,77 | 53,41 | 54,60 | +1,00% | 2,52% | 419.826 |
| 07/12/2020 | 53,21 | 54,62 | 53,21 | 54,05 | +0,10% | 2,65% | 376.224 |
| 04/12/2020 | 53,48 | 54,54 | 53,01 | 54,00 | +1,38% | 2,86% | 302.326 |
| 03/12/2020 | 51,92 | 53,65 | 51,56 | 53,26 | +2,32% | 4,03% | 423.994 |
| 02/12/2020 | 52,46 | 52,91 | 51,82 | 52,05 | -0,52% | 2,09% | 358.912 |
| 01/12/2020 | 53,26 | 53,80 | 51,31 | 52,33 | -0,58% | 4,67% | 519.372 |
| 30/11/2020 | 53,36 | 55,49 | 52,29 | 52,63 | -1,80% | 6,00% | 660.436 |
| 27/11/2020 | 54,87 | 55,70 | 53,04 | 53,60 | -1,70% | 4,84% | 281.166 |
| 25/11/2020 | 53,65 | 54,65 | 53,61 | 54,53 | +1,04% | 1,94% | 312.425 |
| 24/11/2020 | 53,81 | 54,98 | 53,57 | 53,97 | +0,30% | 2,62% | 322.844 |
| 23/11/2020 | 52,07 | 53,91 | 50,99 | 53,81 | +3,64% | 5,62% | 560.890 |
| 20/11/2020 | 50,52 | 52,17 | 50,12 | 51,92 | +2,06% | 4,06% | 335.829 |
| 19/11/2020 | 50,96 | 51,46 | 49,61 | 50,87 | +0,07% | 3,64% | 392.094 |
| 18/11/2020 | 52,17 | 53,02 | 50,79 | 50,83 | -2,04% | 4,28% | 395.300 |
| 17/11/2020 | 50,82 | 52,55 | 50,28 | 51,89 | +1,44% | 4,47% | 552.714 |
| 16/11/2020 | 52,26 | 52,78 | 50,56 | 51,15 | -2,04% | 4,25% | 635.590 |
| 13/11/2020 | 53,34 | 53,84 | 51,65 | 52,22 | -1,36% | 4,11% | 423.352 |